Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis

Neuroimaging Clinics of North America

Volumn 10, Issue 4, 2000, Pages 649-668

  Stuerzebecher, S ^a   Martin, R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MYELIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE ASSOCIATION; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; INFLAMMATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGEN-PRESENTING CELLS; AUTOANTIGENS; BLOOD-BRAIN BARRIER; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN SHEATH; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0034447657     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (215)

1. Limited heterogeneity of T cell receptors form lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention
2. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis inthe Lewis rat
3. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatabilty complex blocking
4. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice
5. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice
6. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype
7. Suppressor cell function in multiple sclerosis - Correlation with clinical disease activity
8. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression
9. The role of B ceils and autoantibodies in multiple sclerosis
10. Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis
11. Genetic analysis of experimental allergic encephalomyelitis in mice
12. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis
13. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
14. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases
15. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell line: Process of selection of lines and characterization of the T cells
16. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes
17. Encephalitogenic potential of myelin basic protein peptide (83-99) in multiple sclerosis - Results of a phase II clinical trial with an altered peptide ligand
18. Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases
19. Multiple sclerosis: Immunotherapy
20. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7
21. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation
22. Induction of relapsing paralysis in experimental allergic encephalomyelitis by bacterial superantigen
23. Dynamics of autoimmune T cell infiltration: Reversal of paralysis and disappearance of inflammation following treatment of experimental encephalomyelitis with a myelin basic protein peptide analog
24. Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitis
25. Monocyte/macrophage differentiation in early multiple sclerosis lesions
26. Endothelial cell presentation of antigen to human T cells
27. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice
28. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis
29. Demyelinating lesions due to Theiler's virus are associated with central nervous system infection
30. T cell receptor b chain usage in myelin basic protein-specific rat T lymphocytes
31. Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA-class II restriction molecules
32. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches
33. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries
34. Inflammatory infiltrates in experimental axonal ion channel encephalitis (EAICE)
35. NBI-5788, an altered MBP (83-99) peptide, induces a T-helper-like immune response in multiple sclerosis patients
36. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: Present status and practical therapeutic guidelines
37. Human microglia activate lymphoproliferative responses to recall viral antigens
38. Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells
39. Glatiramer acetate (Copaxone(R)) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
40. The role of genetic factors in multiple sclerosis susceptibility
41. A full genome search in multiple sclerosis
42. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing IL2
43. Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands
44. Suppression and reversal of allergic encephalomyelitis in rhesus monkeys with basic protein and peptides
45. Astrocytes present myelin basic protein to encephalitogenic T-cell lines
46. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis
47. Antigen presentation in the CNS
48. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells
49. The association of the human herpesvirus-6 and MS
50. Encephalitogenic epitopes of myelin basic protein
51. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity
52. Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms
53. Late complications of immune deviation therapy in a nonhuman primate
54. Identification of autoantibodies associated with myelin damage in multiple sclerosis
55. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases
56. Central nervous system chemokine mRNA accumulation follows leukocyte entry at the onset of murine acute experimental autoimmune encephalomyelitis
57. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: Epitope spreading versus clonal persistence
58. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
59. Molecular mimicry and multiple sclerosis: Degenerate T-cell recognition and the induction of autoimmunity
60. Mechanisms of immunomodulation by glatiramer acetate
61. Encephalitogenicity of murine, but not bovine, DM20 in SJL mice is due to a single amino acid difference in the immunodominant encephalitogenic epitope
62. TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
63. Decreased autologous mixed lymphocyte reaction in multiple sclerosis
64. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex
65. Microglia are the major cell type expressing MHC class II in human white matter
66. Identification of candidate epitopes and molecular mimics in chronic Lyme disease
67. Human T-cell response to myelin basic protein peptide (83-99): Extensive heterogeneity in antigen recognition, function, and phenotype
68. Superantigens: Mechanism of T-cell stimulation and role in immune responses
69. Perivascular microglia cells of the central nervous system are bone marrow derived and present antigen in vivo
70. The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis
71. Biotechnological agents of the immunotherapy of multiple sclerosis. Principles, problems and perspectives
72. Myelin-associated oligodendrocytic basic protein: Identification of an encephalitogenic epitope and association with multiple sclerosis
73. Vaccination against experimental allergic autoimmune encephalomyelitis with T cell receptor peptides
74. Immunological studies in tropical spastic paraparesis
75. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
76. Viral aspects of multiple sclerosis
77. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules
78. A study of the cristalline albumin, gamma globulin and total protein in the cerebrospinal fluid of one hundred cases of multiple sclerosis and in other diseases
79. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor α production
80. Allergic encephalomyelitis: Isolation of an encephalitogenic peptide active in the monkey
81. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
82. Interferon-beta 1b augments activation-induced T-cell death in multiple sclerosis patients
83. The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS)
84. Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis
85. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: Preliminary analysis of MOG T cell epitopes
86. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein
87. Activated human T cells, B cells, and monocytes produced brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?
88. Ia expression and antigen presentation by glia: Strain and cell-type specific differences among rat astrocytes and microglia
89. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100b molecule, a calcium binding protein of astroglia
90. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex
91. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire
92. Genomewide scan of multiple sclerosis in Finnish multiplex families
93. Epidemiology of multiple sclerosis
94. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immuno-deficient hosts rather than protect them from the disease
95. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
96. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease
97. Characterization of measles virus-induced cellular autoimmune reactions against myelin basic protein in Lewis rats
98. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
99. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system
100. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
101. Theiler's virus induced demyelination - Prevention by immunosuppression
102. B lymphocytes producing demyelinating autoantibodies: Development and function in gene-targeted transgenic mice
103. Decreased dependence of myelin basic protein-reactive T ceils on CD28-mediated costimulation in multiple sclerosis patients. A marker for activated/memory T cells
104. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
105. Encephalitogenicity of myelin-associated oligodendrocyte basic protein and 2′,3′-cyclic nucleotide 3′-phosphodi-esterase for Balb/c and SJL mice
106. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
107. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor
108. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans
109. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis
110. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals
111. Persistent intrathecal secretion of oligoclonal, Borrelia burgdorferi-specific IgG in chronic meningo-radiculo-myelitis
112. Immunological aspects of demyelinating diseases
113. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
114. Borrelia burgdorferi-specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis
115. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis
116. Immune regulation by brain cells in the central nervous systems: Microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions
117. Presentation of myelin basic protein by murine cerebral vascular endothelial cells
118. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells
119. Comparative analysis of the outcome of two phase III studies of interferon beta-1b
120. Multiple sclerosis. (Part 1)
121. Multiple sclerosis. (Part 2)
122. Neurological disorders related to HTLV-I and HTLV-II
123. Immunodominance of a low-affinity MHC binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire
124. Restricted replication of lentiviruses
125. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: Involvement of the p75 neurotrophin receptor
126. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
127. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent experimental autoimmune encephalomyelitis induced by multiple myelin antigens
128. T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats
129. Cytokines induce the development of functionally heterogeneous T helper cells subsets
130. Measles virus infection in a transgenic model: Virus-induced immunosuppression and central nervous system disease
131. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities
132. HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation
133. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ
134. Chronic-progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells
135. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis
136. Transfer of allergic encephalomyelitis in rats by means of lymph node cells
137. + T cells from multiple sclerosis
138. + T cells from multiple patients
139. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals
140. Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors
141. The immuno-modulatory profile of phosphodiesterase type 4-specific inhibition of human autoreactive T cell clones: Basis for the treatment of T helper 1 lymphocyte-mediated autoimmune diseases?
142. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vivo activation of lymph node cells by myelin basic protein: Requirement for Lyt-1 + 2-T lymphocytes
143. The neuropathology of multiple sclerosis
144. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis
145. Mechanisms of inflammation in MS tissue: Adhesion molecules and chemokines
146. Chemokines in immune-mediated inflammation of the central nervous system
147. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study
148. Accidents paralytiques au cours du traitment antirabique
149. Evidence for multiple human T cell recognition sites on myelin basic protein
150. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity
151. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys
152. 2′,3′-cyclic nucleotide 3′-phosphodiesterase: A novel candidate autoantigen in demyelinating diseases
153. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins
154. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis
155. CD46 is a cellular receptor for human herpesvirus 6
156. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
157. Measles virus-induced down-regulation of CD46 is associated with enhanced sensitivity to complement-mediated lysis of infected cells
158. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation
159. Innate and adaptive immune responses can be beneficial for CNS repair
160. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis
161. Regulatory T cells in autoimmunity
162. The central nervous system as an immunocompetent organ: Role of glial cells in antigen presentation
163. Induction of multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein
164. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
165. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients
166. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
167. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
168. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice
169. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
170. A critical role for lymphotoxin in experimental allergic encephalomyelitis
171. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes
172. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
173. Presentation of proteolipid proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes
174. Subacute sclerosing panencephalitis
175. Encephalitogenic and immunogenic potential of the stress protein alphaB-crystallin in Biozzi ABH (H-2A(g7)) mice
176. The cerebrospinal fluid in multiple sclerosis
177. Axonal transection in the lesions of multiple sclerosis
178. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides
179. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice
180. Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice
181. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis
182. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients
183. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
184. The small heat-shock protein aB-crystallin as candidate autoantigen in multiple sclerosis
185. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis
186. Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences
187. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells
188. + T cell clones use perforin- or Fas-Fas ligand-mediated pathways for target cell lysis
189. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99)
190. - myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule
191. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides
192. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes
193. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis
194. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis
195. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis
196. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis
197. Interferon beta in the treatment of multiple sclerosis
198. Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11, and transforming growth factor-β1 (TGF-β1) downregulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia
199. Animal models
200. Detection of immunoregulatory B7-1 and IL-10 in human adult microglia
201. Induction of primary T cell responses by human glial cells
202. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1
203. Switch of autoreactive human T cell clones from a Th2 to a TGFβ1 secreting phenotype with low affinity T-cell receptor stimulating peptide/MHC complex
204. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand
205. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy
206. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2 restricted T cell clones from multiple sclerosis patients: Identity of key contact residues in the B-cell and T-cell epitopes
207. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones
208. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
209. T cell clones specific for myelin basic protein induce chronic relapsing EAE and demyelination
210. The T lymphocyte in experimental allergic encephalomyelitis
211. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
212. Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat
213. Molecular mimicry by herpes simplex virus-type 1: Autoimmune disease after viral infection
214. Immune (dys) regulation in multiple sclerosis: Role of the CD95-CD95 ligand system
215. Increased serum levels of soluble CD95 (Apo-1/Fas) in relapsing remitting multiple sclerosis